CYTIMMUNE SCIENCES

cytimmune-sciences-logo

CytImmune Sciences, Inc. created a first-in-class, patented nanomedicine platform, Aurimuneโ„ข. All Aurimune products seek out and destroy the blood vessels inside any primary or metastatic solid tumor. Tumor blood vessel destruction alters the tumor microenvironment in a way that significantly improves the effectiveness of other therapies including chemotherapies, radiation therapies and immunotherapies. CYT-6091, the first generation Aurimune nanomedicine and a first-in-class therapeutic, wa... s shown to be safe and tumor-targeted in a Phase I Clinical Trial. CytImmune is raising funds to advance CYT-6091 through Clinical Trials. All Aurimuneโ„ข products are built around a 27nm gold nanoparticle core. Gold is known to be safe, has a flexible chemistry including forming covalent bonds, and can be manufactured with scale and precision in GMP conditions. All Aurimune products carry Tumor Necrosis Factor Alpha (TNF). Additionally, CytImmune developed a patented gold pegylation technology to prevent Aurimune removal by the immune system. This stealth attribute allows Aurimune to remain in circulation long enough to concentrate inside solid tumors. The Aurimune family of nanomedicines includes CYT-6091 and several second generation, multifunctional nanomedicines. Second generation nanomedicines use TNF to destroy tumor blood vessels, then deliver anti-cancer agents including chemotherapies and targeted biologics into the tumor. Preclinical data indicate this approach concentrates anti-cancer therapies inside solid tumors, which dramatically increases effectiveness while reducing drug-related side effects. Therapeutics delivered by second generation Aurimune products include: โ€ข Common Small Molecule Chemotherapies: Paclitaxel, Doxorubicin, Gemcitabine โ€ข Targeted Therapies and Biologics: TNF, Interferon Gamma, Mono and Bi-valent SMAC Memetics

#SimilarOrganizations #People #Financial #Website #More

CYTIMMUNE SCIENCES

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1988-01-01

Address:
Rockville, Maryland, United States

Country:
United States

Website Url:
http://www.cytimmune.com

Total Employee:
1+

Status:
Active

Contact:
19999999999

Total Funding:
11.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Organization Schema Google Apps For Business Google Maps Typekit


Similar Organizations

aprea-logo

Aprea

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

keros-therapeutics-logo

Keros Therapeutics

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

receptos-logo

Receptos

Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.

Current Employees Featured

not_available_image

Mitchell S. Marder
Mitchell S. Marder Executive V.P., Corporate Development & Chief Legal Officer @ Cytimmune Sciences
Executive V.P., Corporate Development & Chief Legal Officer

dr-giulio-paciotti_image

Dr. Giulio Paciotti
Dr. Giulio Paciotti Chief Science Officer @ Cytimmune Sciences
Chief Science Officer
2019-01-01

david-oarr_image

David Oarr
David Oarr Chief Communications Officer @ Cytimmune Sciences
Chief Communications Officer
2016-02-29

lawrence-tamarkin_image

Lawrence Tamarkin
Lawrence Tamarkin Co-Founder & President & CEO @ Cytimmune Sciences
Co-Founder & President & CEO

Founder


not_available_image

Giulio Paciotti

lawrence-tamarkin_image

Lawrence Tamarkin

Investors List

maryland-venture-fund_image

Maryland Venture Fund

Maryland Venture Fund investment in Venture Round - Cytimmune Sciences

montgomery-county-department-of-economic-development_image

Montgomery County Department of Economic Development

Montgomery County Department of Economic Development investment in Venture Round - Cytimmune Sciences

Official Site Inspections

http://www.cytimmune.com

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Cytimmune Sciences" on Search Engine